We have investigated the use of the protective antigen (PA) and lethal fact
or (LF) components of anthrax toxin as a system for in,vivo delivery of cyt
otoxic T-lymphocyte (CTL) epitopes. During intoxication, PA directs the tra
nslocation of LF into the cytoplasm of mammalian cells. Here we demonstrate
that antiviral immunity can be induced in BALB/c mice immunized with PA pl
us a fusion protein containing the N-terminal 255 amino acids of LF (LFn) a
nd an epitope from the nucleoprotein (NP) of lymphocytic choriomeningitis v
irus. We also demonstrate that BALB/c mice immunized with a single LFn fusi
on protein containing NP and listeriolysin O protein epitopes in tandem mou
nt a CTL response against both pathogens. Furthermore,,ve show that NP-spec
ific CTL are primed in both BALB/c and C57B/6 mice when the mice are immuni
zed with a single fusion containing two epitopes, one presented by Ld and o
ne presented by D-b. The data presented here demonstrate the versatility of
the anthrax toxin delivery system and indicate that this system may be use
d as a general approach to vaccinate outbred populations against a variety
of pathogens.